WallStSmart

Coca-Cola European Partners PLC (CCEP)vsMondelez International Inc (MDLZ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Mondelez International Inc generates 90% more annual revenue ($39.67B vs $20.90B). CCEP leads profitability with a 9.3% profit margin vs 8.9%. MDLZ appears more attractively valued with a PEG of 1.03. MDLZ earns a higher WallStSmart Score of 69/100 (B-).

CCEP

Buy

52

out of 100

Grade: C-

Growth: 6.7Profit: 7.0Value: 4.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

MDLZ

Strong Buy

69

out of 100

Grade: B-

Growth: 6.7Profit: 6.5Value: 4.0Quality: 4.5
Piotroski: 3/9Altman Z: 1.60
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CCEP.

MDLZSignificantly Overvalued (-21.4%)

Margin of Safety

-21.4%

Fair Value

$50.62

Current Price

$62.61

$11.99 premium

UndervaluedFair: $50.62Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP3 strengths · Avg: 9.3/10
Return on EquityProfitability
42.9%10/10

Every $100 of equity generates 43 in profit

EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

MDLZ3 strengths · Avg: 9.0/10
EPS GrowthGrowth
144.9%10/10

Earnings expanding 144.9% YoY

Market CapQuality
$79.23B9/10

Large-cap with strong market position

Operating MarginProfitability
22.0%8/10

Strong operational efficiency at 22.0%

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.363/10

Elevated debt levels

PEG RatioValuation
3.182/10

Expensive relative to growth rate

MDLZ4 concerns · Avg: 3.8/10
P/E RatioValuation
37.6x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
4.1%4/10

4.1% revenue growth

Altman Z-ScoreHealth
1.604/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity, EPS Growth, Free Cash Flow.

Bull Case : MDLZ

The strongest argument for MDLZ centers on EPS Growth, Market Cap, Operating Margin. PEG of 1.03 suggests the stock is reasonably priced for its growth.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : MDLZ

The primary concerns for MDLZ are P/E Ratio, Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

CCEP carries more volatility with a beta of 0.47 — expect wider price swings.

MDLZ is growing revenue faster at 4.1% — sustainability is the question.

CCEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDLZ scores higher overall (69/100 vs 52/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Mondelez International Inc

CONSUMER DEFENSIVE · CONFECTIONERS · USA

Mondelez International, Inc. is an American multinational confectionery, food, holding and beverage and snack food company based in Chicago, Illinois.

Visit Website →

Want to dig deeper into these stocks?